Correlation Between Kura Oncology and Spyre Therapeutics
Can any of the company-specific risk be diversified away by investing in both Kura Oncology and Spyre Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kura Oncology and Spyre Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kura Oncology and Spyre Therapeutics, you can compare the effects of market volatilities on Kura Oncology and Spyre Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kura Oncology with a short position of Spyre Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kura Oncology and Spyre Therapeutics.
Diversification Opportunities for Kura Oncology and Spyre Therapeutics
-0.48 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Kura and Spyre is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Kura Oncology and Spyre Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spyre Therapeutics and Kura Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kura Oncology are associated (or correlated) with Spyre Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spyre Therapeutics has no effect on the direction of Kura Oncology i.e., Kura Oncology and Spyre Therapeutics go up and down completely randomly.
Pair Corralation between Kura Oncology and Spyre Therapeutics
Given the investment horizon of 90 days Kura Oncology is expected to under-perform the Spyre Therapeutics. In addition to that, Kura Oncology is 2.0 times more volatile than Spyre Therapeutics. It trades about -0.23 of its total potential returns per unit of risk. Spyre Therapeutics is currently generating about -0.22 per unit of volatility. If you would invest 3,361 in Spyre Therapeutics on August 24, 2024 and sell it today you would lose (661.00) from holding Spyre Therapeutics or give up 19.67% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Kura Oncology vs. Spyre Therapeutics
Performance |
| Timeline |
| Kura Oncology |
| Spyre Therapeutics |
Kura Oncology and Spyre Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kura Oncology and Spyre Therapeutics
The main advantage of trading using opposite Kura Oncology and Spyre Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kura Oncology position performs unexpectedly, Spyre Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spyre Therapeutics will offset losses from the drop in Spyre Therapeutics' long position.| Kura Oncology vs. ZyVersa Therapeutics | Kura Oncology vs. Sonnet Biotherapeutics Holdings | Kura Oncology vs. Zura Bio Limited | Kura Oncology vs. Phio Pharmaceuticals Corp |
| Spyre Therapeutics vs. ZyVersa Therapeutics | Spyre Therapeutics vs. Sonnet Biotherapeutics Holdings | Spyre Therapeutics vs. Zura Bio Limited | Spyre Therapeutics vs. Phio Pharmaceuticals Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |